- Business Wire•26 days ago
OPKO Health, Inc. , announces that it has completed its previously announced acquisition of Transition Therapeutics, Inc. , by way of a plan of arrangement which was approved by Transition Therapeutics’ shareholders at their meeting held on August 25, 2016.
- Business Wire•last month
OPKO Health, Inc. , announces that at a Special Shareholder Meeting held on August 25, 2016 shareholders of Transition Therapeutics, Inc. holding approximately 93% of the outstanding common shares, voted to approve the previously announced agreement under which OPKO Health will acquire Transition Therapeutics.
- CNW Group•last monthTransition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
Transition Therapeutics Inc. (TTH.TO)
Toronto - Toronto Delayed Price. Currency in CAD
|Day's Range||1.93 - 1.95|
|52wk Range||0.89 - 3.54|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-3.03|
|Avg Vol (3m)||17,065|
|Dividend & Yield||N/A (N/A)|